Related Experiment Video
Updated: Oct 8, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Clinical and Laboratory Factors Associated with Symptom Development in Asymptomatic COVID-19 Patients at the Time of
Hong Sang Oh1, Joon Ho Kim2, Myoung Lyeol Woo3
1Department of Internal Medicine, Armed Forces Capital Hospital, Seongnam, Korea.
Insights
Identifying early symptoms in asymptomatic COVID-19 patients is key for resource allocation during surges. A short exposure-diagnosis interval and abnormal AST levels may indicate symptom development in these cases.
Area of Science:
- Infectious Diseases
- Epidemiology
- Clinical Medicine
Background:
- Efficient medical resource allocation is critical during COVID-19 surges.
- Distinguishing asymptomatic cases is essential for managing healthcare capacity.
Purpose of the Study:
- To identify clinical and epidemiological characteristics of asymptomatic COVID-19 patients.
- To aid in early differentiation of asymptomatic individuals who may develop symptoms.
Main Methods:
- Retrospective analysis of 66 asymptomatic COVID-19 patients diagnosed between January 27 and April 21, 2020.
- Data collected from 13 healthcare facilities in Gyeonggi province, Korea.
- Evaluation of epidemiologic and clinical information.
Main Results:
- An exposure-diagnosis interval within 7 days was a characteristic finding.
- Abnormal aspartate aminotransferase (AST) levels were identified as another key indicator.
- These factors may predict symptom development in initially asymptomatic cases.
Conclusions:
- Early identification of asymptomatic COVID-19 patients likely to develop symptoms can be aided by specific indicators.
- This differentiation can help secure medical resources for mild to moderate COVID-19 cases during surges.
- Further research can refine criteria for predicting symptom onset in asymptomatic individuals.
Abstract:
In preparation for the surge of coronavirus disease 2019 (COVID-19), it is crucial to allocate medical resources efficiently for distinguishing people who remain asymptomatic until the end of the disease. Between January 27, 2020, and April 21, 2020, 517 COVID-19 cases from 13 healthcare facilities in Gyeonggi province, Korea, were identified out of which the epidemiologic and clinical information of 66 asymptomatic patients at the time of diagnosis were analyzed retrospectively. An exposure-diagnosis interval within 7 days and abnormal aspartate aminotransferase levels were identified as characteristic symptom development in asymptomatic COVID-19 patients. If asymptomatic patients without these characteristics at the time of diagnosis could be differentiated early, more medical resources could be secured for mild or moderate cases in this COVID-19 surge.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Pericarditis II: Clinical Features and Diagnostic Tests
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Endocarditis II: Clinical Features of Infective Endocarditis
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

